Get paper from

journal cover

Acute bacterial maxillary sinusitis: results of U.S. and European comparative therapy trials

The American Journal of Medicine

Jun 22, 1992

R W Nielsen

Get paper from

Abstract

Loracarbef, which is the first agent of the carbacephem class of beta-lactam antibiotics to be developed, provides good activity against a broad spectrum of bacteria. A single-blinded, randomized, parallel clinical trial in 10 centers in the United States compared the efficacy and safet...read more

Mentioned in this Paper

Single-Masked Study
Double-Blind Method
Maxillary Sinusitis
Amoxicillin / Clavulanate
Doxycycline
Augmentin
Loracarbef
Carbacephems
Polychemotherapy
Clinical Trial [Publication Type]
Paper Details
References
  • References10
  • Citations4
1

Acute bacterial maxillary sinusitis: results of U.S. and European comparative therapy trials

The American Journal of Medicine

Jun 22, 1992

R W Nielsen

PMID: 1621749

DOI: 10.1016/0002-9343(92)90611-e

Abstract

Loracarbef, which is the first agent of the carbacephem class of beta-lactam antibiotics to be developed, provides good activity against a broad spectrum of bacteria. A single-blinded, randomized, parallel clinical trial in 10 centers in the United States compared the efficacy and safet...read more

Mentioned in this Paper

Single-Masked Study
Double-Blind Method
Maxillary Sinusitis
Amoxicillin / Clavulanate
Doxycycline

Related Papers

Paper Details
References
  • References10
  • Citations4
1

Get paper from

/papers/acute-bacterial-maxillary-sinusitis-results-of-us/1621749